CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangzhou Potent Medical Equipment JSI is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangzhou Potent Medical Equipment JSI
Phone: +86 2037396970p:+86 2037396970 GUANGZHOU, GNG  China Fax: +86 2037396979f:+86 2037396979

Business Summary
Guangzhou Potent Medical Equipment Joint-Stock Inc is a company engaged in research and development, production and sales of medical devices, as well as the provision of technical services. The Company's products include holmium laser therapy machines, urodynamic analyzers, body shock wave lithotripters and so on. The Company sells both its products and the products from other companies to clients through direct sales and agent sales.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201512/31/2015Yes----

General Information
Outstanding Shares: 12,500,000 (As of 12/31/2015)
Fax Number: +86 2037396979


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023